Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07072039 · ClinicalTrials.gov registry record · NA
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
A NA study of COPD (Chronic Obstructive Pulmonary Disease), sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07072039: Recruiting NA study of COPD (Chronic Obstructive Pulmonary Disease), sponsored by University of Massachusetts, Worcester.
NCT07072039 is a NA study of COPD (Chronic Obstructive Pulmonary Disease) that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 50 participants, below the 729-participant average among 9 other COPD (Chronic Obstructive Pulmonary Disease) trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07072039, a NA study of COPD (Chronic Obstructive Pulmonary Disease), is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic Obstructive Pulmonary Disease (COPD) is a serious lung condition that affects millions of people in the United States. Each year, it leads to about 150,000 deaths, nearly 900,000 emergency room visits, and 700,000 hospital stays. When COPD symptoms suddenly get worse-called an exacerbation-it can seriously harm a person's quality of life and often requires emergency care. Treating these flare-ups early can help prevent hospital visits, but right now, there aren't many good ways to make sure people get care quickly. Mobile Integrated Health (MIH) programs send specially trained paramedics, guided remotely by doctors, to care for patients in their homes. This approach could help people with COPD get faster, more effective care without needing to go to the hospital. In this project, the investigators are testing a new program called PEACE (Paramedic Evaluation for Acute COPD Exacerbation). The PEACE program sends community paramedics to patients' homes-when needed and in partnership with their regular doctors-to manage worsening COPD symptoms early. The study team will adapt the PEACE program to meet the needs of adults living at home with moderate to severe COPD, gather feedback from patients and healthcare providers, and run a small pilot study to see if the program is practical and helpful.
Primary Outcome
Ratio of patients enrolled to total patients approached
Conditions Studied
Interventions
- PROCEDURE Paramedic Evaluation for acute COPD Exacerbation
Study Locations (1)
Massachusetts
- University of Massachusetts Chan Medical School - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2029-09-01 |
| Phase | NA |
What NCT07072039 shows while recruiting
NCT07072039 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 729-participant average among 9 other COPD (Chronic Obstructive Pulmonary Disease) trials with a reported enrollment target (93% lower).
The record links to 1 condition, with COPD (Chronic Obstructive Pulmonary Disease) appearing as the primary indexed condition, and to 1 intervention - of which Paramedic Evaluation for acute COPD Exacerbation is the first listed.
NCT07072039 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07072039 about?
NCT07072039 is a clinical study titled "Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation". Chronic Obstructive Pulmonary Disease (COPD) is a serious lung condition that affects millions of people in the United States. Each year, it leads to about 150,000 deaths, nearly 900,000 emergency room visits, and 700,000 hospital stays. When COPD symptoms suddenly get worse-called an exacerbation-i...
What is the current status of trial NCT07072039?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-10-01. Estimated completion is 2029-09-01.
What conditions does trial NCT07072039 study?
This clinical trial studies the following conditions: COPD (Chronic Obstructive Pulmonary Disease).
What interventions are being tested in trial NCT07072039?
The interventions under investigation include: Paramedic Evaluation for acute COPD Exacerbation (PROCEDURE).
Who is sponsoring clinical trial NCT07072039?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07072039 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD (Chronic Obstructive Pulmonary Disease)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07072039's enrollment target sits among peer trials
50 8th of 9 higher than 2 of 9 other COPD (Chronic Obstructive Pulmonary Disease) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COPD (Chronic Obstructive Pulmonary Disease) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Photon-counting CT in Chest Imaging
RECRUITING · NA
-
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
RECRUITING · NA
-
OMEGA - Dietary Intervention - COPD Trial
RECRUITING · NA
-
University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
RECRUITING
-
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RECRUITING · Phase 3
-
Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI